1. Introduction
Hysterectomy is the most frequently performed gynecological surgery globally, with approaches including endoscopic, abdominal and vaginal methods [1]. Vaginal hysterectomy (VH) is the preferred surgical technique for suitable patients [2], as it is less invasive compared to other methods and offers benefits such as reduced recovery time, lower risk of infection, and minimal postoperative pain. However, its application in clinical practice may be constrained by limited imaging capabilities and challenges in manipulation techniques [3]. Abdominal hysterectomy (AH) is associated with an increased risk of pelvic organ prolapse (POP) in comparison to other surgical procedures, as it results in greater damage to pelvic support tissues [4,5]. With the advent and widespread adoption of endoscopic surgery, there has been a noted decline in the rates of abdominal hysterectomy, while the incidence of laparoscopic hysterectomy has progressively risen [6]. Laparoscopic hysterectomy is favored over open abdominal hysterectomy for patients for whom vaginal hysterectomy is not feasible [7]. The NOTES technique, which involves accessing the peritoneal cavity through natural orifices, was first introduced in 2004 [8]. A study conducted in 2012 established that the NOTES technique, when performed vaginally (vNOTES), is both safe and feasible. This research indicated that surgeries conducted through natural orifices yield successful outcomes when executed by experienced surgeons and with appropriate patient selection [9]. VNOTES represents an innovative surgical approach that has gained increasing attention in recent years. This technique integrates the minimally invasive characteristics of endoscopic procedures with the benefits of vaginal surgery, utilizing natural orifices [10]. Studies have demonstrated that the vNOTES technique offers several advantages over conventional laparoscopy. It has been reported that this method results in reduced intraoperative blood loss, decreased postoperative pain, and an accelerated recovery process. Furthermore, vNOTES is aesthetically advantageous, as it leaves no abdominal incision scar, thereby providing superior cosmetic outcomes [11,12,13].
Pelvic organ prolapse (POP) is a prevalent health issue that substantially impacts women’s daily activities, social interactions, and sexual functioning [14]. Pelvic organ prolapse (POP) is characterized by the downward displacement of one or more pelvic organs, including the anterior vaginal wall, posterior vaginal wall, uterus, or vaginal cuff. This condition may present in patients with a variety of symptoms, such as urinary and defecation issues, pelvic pain, and sexual dysfunction [7]. Hysterectomy can impact the anatomical and neurological integrity of the pelvic floor, potentially leading to its weakening and thereby increasing the risk of POP. However, in addition to hysterectomy, factors such as age, obesity, vaginal delivery, parity, and the underlying reason for surgery also significantly contribute to the development of POP [4,5,15].
Hysterectomy may lead to pelvic floor weakness by modifying anatomical structures and nerve supply [4,5,15]. The incidence of vaginal cuff prolapse necessitating surgical intervention following hysterectomy exhibits variability across different studies in the literature. One study reported this rate to be 6.25% [16], whereas another study found the incidence of prolapse requiring surgical correction post-hysterectomy to range between 1.3 and 4.2 per 1000 woman-years [17]. These findings indicate that the risk of vaginal cuff prolapse after hysterectomy should be regarded as a significant clinical concern. Vaginally performed vNOTES results in reduced trauma to the abdominal muscles and pelvic anatomy, as it is conducted without breaching the anterior abdominal wall. Consequently, this approach may lead to a decreased incidence of prolapse and sexual dysfunction. This study aimed to conduct a comparative evaluation of the surgical parameters, the development of pelvic organ prolapse (POP) during a one-year follow-up period and the effects on sexual function in patients who underwent total laparoscopic hysterectomy (TLH) and vNOTES hysterectomy.
2. Materials and Methods
In this retrospective, comparative study, the medical records of patients who underwent total laparoscopic hysterectomy (TLH) (group 1) and vaginal natural orifice transluminal endoscopic surgery (vNOTES) (group 2) hysterectomy between January 2023 and January 2024 at the Gynecology and Obstetrics Clinic of the University of Health Sciences Gazi Yasargil Training and Research Hospital were reviewed. The study adhered to the ethical principles for medical research involving human subjects as outlined in the Declaration of Helsinki (Diyarbakır Gazi Yaşargil Training and Research Hospital Ethics Committee no: 298/2024).
The study cohort comprised 84 patients, aged 30 to 80 years, who underwent 42 vNOTES hysterectomies and 42 TLHs for benign uterine pathologies. The primary objective was to compare the impact of these two hysterectomy techniques on pelvic organ prolapse and female sexual function in the postoperative period.
Inclusion criteria encompassed patients who underwent hysterectomy for benign conditions such as uterine leiomyomas (fibroids), adenomyosis, endometrial hyperplasia, abnormal uterine bleeding, cervical dysplasia, or cervical intraepithelial neoplasia, who had stage 0 or 1 pelvic organ prolapse according to the pelvic organ prolapse quantification (POP-Q) system prior to surgery, who were sexually active, and who were followed up for a minimum of 12 months post-surgery. Exclusion criteria included patients who underwent hysterectomy for malignant pathologies, those with a diagnosis of pelvic organ prolapse of stage 2 or higher according to the POP-Q system, those with a history of previous pelvic surgery, intraoperative complications, chronic pelvic pain, neurological diseases, or pelvic radiation history, and those lacking complete follow-up data within 12 months post-surgery.
During the postoperative follow-up period, patient records were retrospectively analyzed 12 months after the operation. This analysis utilized the pelvic organ prolapse quantification (POP-Q) system for evaluating pelvic organ prolapse and the Female Sexual Function Index (FSFI) scale for assessing sexual function. The FSFI, which was developed to evaluate female sexual function and possesses established scientific validity, is widely employed as a reliable assessment tool. The FSFI aims to objectively measure female sexual function and is extensively used in clinical applications and research. The FSFI evaluates women’s sexual function across domains such as sexual desire, arousal, vaginal lubrication, orgasm, sexual pain, and satisfaction, with each domain scored from 0 to 6, providing a comprehensive assessment of women’s sexual health status. FSFI questionnaires were administered to patients both pre- and post-surgery.
The pelvic organ prolapse quantification (POP-Q) system is a widely utilized method for grading pelvic organ prolapse and assessing pelvic floor function in women. This system determines the severity of prolapse through precise measurements taken at various anatomical landmarks [14]. Measurements were conducted during preoperative and postoperative follow-up appointments, with patients positioned in the lithotomy position and performing the Valsalva maneuver to evaluate the severity of pelvic organ prolapse. Total vaginal length measurements were recorded while the patient was at rest. During these evaluations, measurements in centimeters were taken at two points in the anterior compartment (Aa and Ba), two points in the posterior compartment (Ap and Bp), the genital hiatus (gh), the perineal body (pb) and the vaginal length.
The staging of pelvic organ prolapse was based on the most distal point of prolapse, using the hymen as the reference point. This retrospective study facilitated a comprehensive evaluation of anatomical and functional outcomes following surgery. All patients underwent a preoperative gynecologic examination and cervical smear test and were assessed via ultrasonography. Informed consent was obtained from all patients preoperatively. Data on age, body mass index (BMI), parity, age, and surgical indications were recorded. Additionally, preoperative and postoperative hematocrit values, operation duration, and hospitalization time were documented. All surgical procedures were performed by surgeons with advanced expertise in gynecologic endoscopic surgery.
Both groups underwent surgical procedures under general anesthesia, positioned in the lithotomy stance with endotracheal intubation. Preoperatively, patients received 2 or 3 g of intravenous cefazolin, contingent upon their body mass index (BMI). During the operation, the insertion of urinary and nasogastric catheters was implemented for all patients, a standard practice aimed at ensuring the safety and efficiency of the surgical process.
2.1. vNOTES Hysterectomy Procedure
Patients were positioned in the high lithotomy position. The anterior and posterior cervical lips were secured using a tenaculum. A circumferential cervical incision was executed utilizing monopolar cautery. The cervical fascia was meticulously separated from the vaginal mucosa through dissection. A posterior colpotomy was created via sharp dissection. Subsequently, the cardinal and sacrouterine ligaments were grasped, transected, ligated, and suspended with sutures. An anterior colpotomy was then conducted. The abdominal cavity was accessed with a retractor, and the abdomen was inspected. Following this, the metal retractors were removed, and the GelPoint vPath (Applied Medical, Rancho Santo Margarita, CA, USA) was inserted. Pneumoperitoneum was established using CO2 insufflation, with the pressure adjusted to 12 mmHg. A total of three trocars were employed. A 30° camera was introduced through a 10 mm trocar, while additional laparoscopic instruments were inserted through 5 mm trocars. Bipolar electrocoagulation (LigaSure™, Covidien Company, Mansfield, MA, USA) was utilized for tissue dissection. The uterine vessels, adnexal pedicles, and infundibulopelvic ligaments were transected in both caudal and cranial directions. The specimen was extracted vaginally. The vaginal cuff was peritonized and sutured using 1-0 (Vicryl®, Ethicon, Piscataway, NJ, USA) sutures.
2.2. TLH Procedure
All patients underwent surgery in the lithotomy position. A Veress needle (Ethicon Endo-surgery, Inc., Piscataway, NJ, USA) was introduced through the umbilical incision, and the abdomen was insufflated with CO2 to a pressure of 20 mmHg. A 10 mm trocar was inserted into the abdomen via the umbilicus, followed by the insertion of a 30° 10 mm optical trocar. The patient was then positioned in the Trendelenburg position. Subsequently, the pressure was reduced to 15 mmHg. A uterine manipulator (RUMI-II®, CooperSurgical, Trumbull, CT, USA) was employed to manipulate the uterus in all cases. Upon visualization of all abdominal organs, 5 mm trocars were inserted, two on the left and one on the right. Bipolar electrocoagulation (LigaSure™, Covidien Company, Mansfield, MA, USA) was utilized as the energy modality. The uterine artery and ligaments were transected in a cranial to caudal direction. The bladder was dissected away from the uterus. The parametrial tissue surrounding the cervix was dissected with the assistance of LigaSure. A circular colpotomy was performed over the uterosacral ligament using monopolar cautery, and the uterus was completely detached from the vagina. The uterus and adnexa were extracted from the abdomen through the vagina. The vaginal cuff was closed using laparoscopic 1-0 suture (Vicryl®, Ethicon, Piscataway, NJ, USA).
2.3. Power Analysis
A post hoc power analysis was conducted for the Mann–Whitney U test employed in this study. Assuming a moderate effect size (Cohen’s d = 0.55), with a total sample size (n = 84) and an error rate of 5% (α = 0.05), the statistical power of the study was calculated to be 80.4%. The 80% power level, which is generally accepted in the literature, suggests that the probability of detecting a significant effect is adequate. Therefore, the obtained value of 80.4% is deemed appropriate in terms of the study’s reliability.
2.4. Statistical Analysis Method
In this study, SPSS 26 software was employed for all statistical analyses. For the comparison of the TLH and vNOTES groups across various parameters, descriptive statistics, including median, minimum, maximum, frequency, and percentage values, as well as central tendencies and distributions of variables, were summarized in accordance with the data characteristics. The Mann–Whitney U Test, which is appropriate for evaluating differences between two independent groups when parametric assumptions are unmet, was utilized. Additionally, the Chi-Square (χ2) Test was applied to compare categorical variables. Furthermore, the Wilcoxon Signed Rank Test was employed for comparisons between two dependent groups to assess differences between preoperative and postoperative measurements. This test was specifically chosen to evaluate changes in preoperative and postoperative variables for both surgical methods. Notably, Wilcoxon analysis was conducted for data such as vaginal length, preoperative and postoperative pelvic anatomical variables (Aa, Ap, Ba, Bp, Gh), and hematocrit levels, with statistically significant changes observed postoperatively.
3. Results
When the demographic and clinical characteristics of the patients in both groups were analyzed in Table 1, it was observed that the majority of the patients were in menopause and their body mass index (BMI) values were below 30. In terms of age distribution, the median age was below 55 years in both groups. The median age was 49 (32–73) in the TLH group and 51 (35–75) in the vNOTES group. BMI values were similar in both groups with a median of 28 (21–40). When menopausal status was evaluated, 65.1% (n = 28) of the TLH group and 58.5% (n = 24) of the vNOTES group were in menopause. There was no statistical difference between the groups in terms of age (p < 0.299), BMI (p < 0.819), parity (p < 0.615), surgical indications and menopausal status (p < 0.535) (p > 0.05). These findings revealed that both groups had similar characteristics in terms of age, BMI, menopausal status and indications. Statistical analysis showed that there were no differences between the groups in terms of age (p = 0.299), BMI (p = 0.819), menopausal status (p = 0.535) and indications (p = 0.362). The most common indications for surgery in patients undergoing vNOTES and TLH were myoma uteri and abnormal uterine bleeding. Myoma uteri was detected in 53.7% (n = 22) of patients in the vNOTES group and 44.2% (n = 19) in the TLH group, while abnormal uterine bleeding was observed in 29.3% (n = 12) in the vNOTES group and 25.6% (n = 11) in the TLH group. There was no significant difference between TLH and vNOTES groups in terms of surgical indications (p > 0.05).
These findings suggest that TLH and vNOTES methods can be safely applied in patient groups with similar demographic and clinical characteristics.
Table 2 provides a comparative analysis of the TLH and VNOTES techniques with respect to surgical duration, as well as preoperative and postoperative hematocrit levels and hospitalization duration. The VNOTES group demonstrated a significantly reduced surgical time (58) compared to the TLH group (80) (p < 0.001). However, no statistically significant differences were observed between the two methods concerning preoperative and postoperative hematocrit values or the length of hospitalization (p > 0.05).
Table 3 presents a comparison of preoperative and postoperative parameters for the TLH and vNOTES methods, specifically focusing on POP-Q (pelvic organ prolapse quantification) and FSFI (Female Sexual Function Index) scores. The analysis revealed no significant difference in preoperative FSFI values between the TLH and vNOTES groups (p > 0.05), suggesting comparability in terms of FSFI. Similarly, the comparison of postoperative FSFI values indicated no significant difference between the two groups (p > 0.05).
In this study, a comparison of the preoperative POP-Q parameters between the groups revealed that all parameters were similar, with the exception of Aa (p). Postoperative analysis indicated that the v-NOTES group exhibited superior outcomes in terms of POP-Q parameters Aa, Ba, gh, and vaginal length. However, when evaluating the impact of surgery on these parameters through preoperative and postoperative change analysis, the v-NOTES group demonstrated a statistically significant improvement over the TLH group only in the Aa parameter (p < 0.003), while the gh variable approached borderline significance with p = 0.051. Furthermore, the definitive pathological findings in patients with a preliminary diagnosis of abnormal uterine bleeding were consistent with preoperative assessments, including proliferative or secretory endometrium, atypical endometrial hyperplasia, cervical carcinoma in situ (notably in two young patients in their thirties), and endometrial intraepithelial neoplasia.
The definitive pathological findings for patients initially diagnosed with abnormal uterine bleeding were consistent with conditions such as proliferative or secretory endometrium, atypical endometrial hyperplasia, endometrial intraepithelial neoplasia, and cervical carcinoma in situ. Notably, these diagnoses were observed in two young patients in their thirties. Additionally, multiple and widely distributed fibroids were identified in both patient cohorts. Pathological examination of all myoma cases confirmed benign characteristics.
4. Discussion
Hysterectomy is among the most frequently performed procedures in gynecologic surgery; however, it is associated with various complications in both the early and late postoperative periods. Notably, pelvic organ prolapse (POP) and sexual dysfunction are significant concerns [1,15]. This study aims to compare the incidence of POP and the impact on sexual function in patients undergoing hysterectomy via total laparoscopic hysterectomy (TLH) and vaginal natural orifice transluminal endoscopic surgery (vNOTES) methods.
Hysterectomy may pose a risk factor for POP by compromising the anatomical and neurological integrity of the pelvic floor. Several studies indicate that vaginal support mechanisms may be weakened post-hysterectomy, thereby increasing the risk of POP [18]. In the context of benign indications, no significant difference in POP prevalence was observed between TLH and vaginal hysterectomy (VH) in non-prolapse conditions [18]. Aigmueller et al. reported a 6.25% incidence of prolapse necessitating surgery following hysterectomy [16], whereas Dallenbach et al. documented a need for surgery at a rate of 1.3–4.2 per 1000 per year [17]. In the present study, no patients required surgical intervention for postoperative prolapse after a one-year follow-up. This discrepancy may be attributed to the relatively short duration of the follow-up period.
In the preoperative evaluation of patients in both groups, the stage was classified as 0–1 according to the pelvic organ prolapse quantification (Pop-Q) system. Postoperatively, patients in both groups were similarly assessed as stage 0–1 using the Pop-Q staging. A notable strength of this study is the absence of preoperative prolapse in both groups, which underscores the role of hysterectomy in the etiology of prolapse. However, the vNOTES approach yielded superior anatomical outcomes in postoperative Ba (p = 0.015), postoperative Aa (p = 0.011), and postoperative Gh (p = 0.044). These findings indicate that vNOTES may offer enhanced improvement in anterior vaginal wall support and potentially augment pelvic support in this region.
It is well established that factors such as age, obesity, a history of vaginal delivery and connective tissue weakness significantly contribute to the development of POP [19]. The incidence of pelvic organ prolapse (POP) is significantly correlated with increasing age [20]. Childbirth is identified as the primary risk factor for POP. Current evidence indicates that the process of childbirth results in damage to the nerves, fascia and muscles of the pelvic floor [21]. Obesity constitutes a significant risk factor for pelvic floor dysfunction. The primary cause of pelvic organ prolapse (POP) in obese women is increased intra-abdominal pressure, which leads to the weakening of pelvic floor tissues [22]. This study’s findings reveal that the demographic and clinical characteristics of both surgical groups were similar, suggesting that the observed outcomes are attributable to differences in surgical intervention, thereby enhancing the study’s comparability.
Pelvic organ prolapse (POP) is identified during physical examinations in approximately 41% to 50% of women, yet only 3% exhibit symptoms [23]. In this study, both symptomatic and asymptomatic patients were assessed preoperatively and postoperatively to more accurately determine the true incidence of pelvic organ prolapse. This methodological rigor significantly contributes to the scientific validity of the study’s findings.
In our study, we found that vNOTES (58) was statistically significantly shorter than TLH (80) in terms of surgical time (p < 0.001). The use of vNOTES may be attributed to its facilitation of surgical access through natural orifices, thereby minimizing the need for additional trocar placement and reducing the dissection times typically required during laparoscopic procedures. Furthermore, previous studies have demonstrated that vNOTES is associated with shorter surgical durations and enhances the efficiency of the operative process [12].
Female sexual dysfunction is a complex condition influenced by the interplay of physiological, psychological, and social factors. The impact of hysterectomy on sexual function varies [24]. Although it is commonly believed that hysterectomy does not adversely affect sexual function, sexual issues may arise due to factors such as vaginal narrowing, nerve damage, and psychological influences [25,26]. The effects of different types of hysterectomy on sexual function have not been fully elucidated. In a study comparing total abdominal hysterectomy and vaginal hysterectomy (VH), it was observed that vaginal length decreased and the incidence of dyspareunia increased in patients who underwent vaginal hysterectomy [27]. Another study showed significant improvements in sexual function and quality of life in the postoperative period, regardless of the type of hysterectomy performed [24]. In our study, the sexual functions of the patients were evaluated with FSFI scores and no significant change was observed in the preoperative and postoperative periods for either surgical method (p > 0.05). Although a change in vaginal length was observed following hysterectomy, this difference did not reach statistical significance (p = 0.340). The findings clearly indicate that neither surgical method significantly impacts sexual function or vaginal length. These results imply that the short-term effects of surgery are limited, necessitating more comprehensive and long-term studies to ascertain the long-term effects. Furthermore, the results suggest that vNOTES yields outcomes comparable to TLH in terms of sexual function, while offering superior anatomical results. A notable strength of this study is its documentation of preoperative and postoperative FSFI values, allowing for the observation of these changes. Consequently, it was concluded that the impact of hysterectomy on sexual function was not statistically significant.
In patients presenting with an enlarged uterus and multiple fibroids, vNOTES is a beneficial technique as it facilitates access to uterine vessels and permits the safe dissection of ligaments under direct optical visualization [28]. In our study, multi-tip fibroids were detected in 19 (44.2%) of the patients in the vNOTES group, and all these cases were treated successfully and without complications without the need for an additional surgical method.
Housmans et al. reported that vNOTES resulted in shorter operative time, shorter hospital stay and lower estimated blood loss [24]. In our study, a similar statistically significant difference was observed between the groups regarding the duration of surgery (VNOTES:58 TLH:80 p < 0.001). However, we did not find any significant difference between preoperative and postoperative hematocrit values and length of hospitalization. Compared to TLH, VNOTES offers significant advantages such as shorter surgical time and faster postoperative recovery, in addition to allowing clearer visualization of pelvic anatomical structures [29]. Factors such as cosmetic advantages due to the absence of scar formation and decreased risk of trocar-related complications have been effective in increasing the prevalence of this technique [10]. In the present study, it was observed that patients reported significant satisfaction with the cosmetic outcomes at the one-year postoperative follow-up. These findings suggest that vNOTES may offer a more advantageous alternative to TLH. Moreover, further research is warranted to assess the impact of hysterectomy on the development of prolapse and the long-term effects of the surgical technique on pelvic floor integrity. However, the study is subject to certain limitations, including its retrospective design, relatively small patient cohort and the absence of long-term follow-up data. It is recommended that future large-scale, randomized controlled trials be conducted to evaluate the long-term outcomes of vNOTES in a more comprehensive manner.
5. Conclusions
The vNOTES technique represents a significant option in pelvic surgery practice, which is attributable to its reduced surgical duration, enhanced anterior vaginal support, and cosmetic benefits in comparison to TLH. Furthermore, the comparative assessment of the impacts of various surgical techniques on the anterior and posterior compartments of the vagina offers valuable clinical contributions to the literature. Nonetheless, further research is required to elucidate the long-term outcomes of this method and its implications for the development of POP.
Conceptualization, M.B.; methodology, S.E. (Selami Erdem).; software, B.C.; validation, İ.B.; formal analysis, M.O.; investigation, S.A.; resources, C.B.; data curation, C.Ş.; writing—original draft preparation, K.A.; writing—review and editing, M.A.H.; visualization, A.D.E.; supervision, S.E. (Serhat Ege), S.B.K.; project administration, S.C.O. All authors have read and agreed to the published version of the manuscript.
This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Diyarbakır Gazi Yaşargil Training and Research Hospital Ethics Committee NO:298/2024 on 17 December 2024.
Written informed consent was obtained from the patient(s) to publish this paper.
Data are contained within the article.
The authors declare no conflicts of interest.
The following abbreviations are used in this manuscript:
TLH | Total laparoscopic hysterectomy. |
Vnotes | Vaginal natural orifice transluminal endoscopic surgery. |
POP | Pelvic organ prolapse. |
POPQ | Pelvic organ prolapse quantification. |
FSFI | Female Sexual Function Index. |
BMI | Body mass index. |
TVL | Total vaginal length. |
Aa and Ba | Anterior wall. |
GH | Genital hiatus. |
PB | Perineal body. |
Ap and Bp | Posterior wall. |
VH | Vaginal hysterectomy. |
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Comparison of surgical approaches according to demographic and clinical characteristics.
Variables | TLH | vNOTES Median (Min–Max) | U-X2 | p | |
---|---|---|---|---|---|
Age | 49 (32–73) | 51 (35–75) | 765,500 | 0.299 | |
BMI | 28 (21–40) | 28 (21–40) | 856,500 | 0.819 | |
Parity | 4 (0–7) | 4 (0–12) | 826,000 | 0.615 | |
Indications | Abnormal Uterine Bleeding | 11 (25.6) | 12 (29.3) | 4341 | 0.362 |
Uterine Myoma | 19 (44.2) | 22 (53.7) | |||
Endometrial Hyperplasia | 9 (20.9) | 4 (9.8) | |||
Cervical Intraepithelial Lesion | 2 (4.7) | 3 (7.3) | |||
Adenomyosis | 2 (4.7) | 0 (0.0) | |||
Menopause | Positive | 28 (65.1) | 24 (58.5) | 0.385 | 0.535 |
Negative | 15 (34.9) | 17 (41.5) |
BMI: body mass index; p < 0.05 was considered statistically significant.
Comparison of surgical time, hematocrit values and length of hospitalization.
Variables | TLH | vNOTES | U | p * |
---|---|---|---|---|
Surgical Duration | 80 (48–90) | 58 (55–79) | 103,000 | 0.001 * |
Preoperative Htc | 40 (30–48) | 40 (29–47) | 879,000 | 0.982 |
Postoperative Htc | 34 (24–43) | 35 (24–44) | 869,000 | 0.911 |
Length of Stay | 2 (1–5) | 2 (1–4) | 739,000 | 0.148 |
* p < 0.05 was considered statistically significant. Htc: hematocrit.
TLH and vNOTES comparison of POP-Q and FSFI scores and change before and after surgery.
Variables | Tlh | Vnotes Median (Min–Max) | U | p |
---|---|---|---|---|
Preoperative Op FSFI | 26.3 (20.3–31) | 26.5 (19–31.2) | 874,500 | 0.950 |
Preoperative Op FSFI | 24.4 (17.2–29.6) | 24.4 (17.2–29.6) | 880,500 | 0.993 |
Preoperative POP-Q | ||||
Preoperative Op Aa | −2 (−3–−1) | −2 (−3–−1) | 862,500 | 0.853 |
Preoperative Op Ba | −3 (−3–0) | −3 (−3–−2) | 640,000 | 0.012 |
Preoperative Op Ap | −2 (−3–0) | −2 (−3–2) | 834,500 | 0.645 |
Preoperative Op Bp | −3 (−3–−3) | −3 (−3–−3) | 881,500 | 1.000 |
Preoperative Op Gh | 5.3 (3.2–7.0) | 5.5 (3.8–7.2) | 603,000 | 0.166 |
Preoperative Op Pb | 3 (1.8–4.6) | 3 (2–4.4) | 863,300 | 0.164 |
Preoperative TVL | 8 (7–10) | 8 (7–9) | 804,000 | 0.445 |
Postoperative POP-Q | ||||
Postoperative Op Aa | −2 (−3–0) | −2 (−3–−1) | 623,500 | 0.011 |
Postoperative Op Ba | −2 (−3–1) | −3 (−3–−2) | 640,000 | 0.015 |
Postoperative Op Ap | −2 (−3–0) | −2 (−3–2) | 741,000 | 0.166 |
Postoperative Op Bp | −3 (−3–−2) | −3 (−3–−2) | 807,500 | 0.369 |
Postoperative Vaginal Length | 7 (6–9) | 8 (6–9) | 784,500 | 0.340 |
Postoperative Op Gh | 4.5 (3–7) | 5 (3.5–7) | 658,500 | 0.044 |
Postoperative Op Pb | 3 (1.8–4.4) | 3 (1.9–4.4) | 855,000 | 0.811 |
Preoperative and postoperative POP-Q and FSFI change | ||||
FSFI | 2 (0–4.1) | 2 (0–3) | 814,000 | 0.543 |
Aa | 0 (−2–1) | 0 (−1–2) | 590,500 | 0.003 |
Ba | 0 (−3–0) | 0 (−1–0) | 823,500 | 0.456 |
Ap | 0 (−1–0) | 0 (−1–0) | 742,000 | 0.060 |
Bp | 0 (−1–0) | 0 (−1–0) | 807,500 | 0.369 |
TVL CHANGE | 1 (0–2) | 1 (0–2) | 837,000 | 0.605 |
Gh | 0.2 (0–0.6) | 0.3 (0–1) | 666,000 | 0.051 |
Pb | 1 (0–0.2) | 0 (0–0.4) | 860,500 | 0.837 |
p < 0.05 was considered statistically significant. Aa; anterior point A: Ba; anterior point B; Gh; genital hiatus: Pb; perineal body: Ap; posterior point A. Bp; posterior point B: TVL; total vaginal length. POP-Q; pelvic organ prolapse quantification. FSFI; female Sexual Function Index.
1. Aarts, J.W.; Nieboer, T.E.; Johnson, N.; Tavender, E.; Garry, R.; Mol, B.W.; Kluivers, K.B. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst. Rev.; 2015; 2015, CD003677.Update in Cochrane Database Syst Rev. 2023, 8, CD003677 [DOI: https://dx.doi.org/10.1002/14651858.cd003677.pub5] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26264829]
2. Naz, M.; Zafar, H.; Fatima, U.; Fatima, A.; Yasmeen, A.; Irshad, F. Resurgence of vaginal route of hysterectomy: Comparison based outcomes of abdominal and non-descent vaginal hysterectomy. Prof. Med. J.; 2024; 31, pp. 1595-1602. [DOI: https://dx.doi.org/10.29309/tpmj/2024.31.11.8235]
3. Moen, M.D.; Noone, M.B.; Elser, D.M. Urogynecology Network. Natural orifice hysterectomy. Int. Urogynecol. J. Pelvic Floor Dysfunct.; 2008; 19, pp. 1189-1192. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18545864][DOI: https://dx.doi.org/10.1007/s00192-008-0659-y]
4. Lykke, R.; Blaakær, J.; Ottesen, B.; Gimbel, H. Pelvic organ prolapse (POP) surgery among Danish women hysterectomized for benign conditions: Age at hysterectomy, age at subsequent POP operation, and risk of POP after hysterectomy. Int. Urogynecol. J.; 2015; 26, pp. 527-532. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25182152]
5. Altman, D.; Falconer, C.; Cnattingius, S.; Granath, F. Pelvic organ prolapse surgery following hysterectomy on benign indications. Am. J. Obstet. Gynecol.; 2008; 198, pp. 572.e1-572.e6. [DOI: https://dx.doi.org/10.1016/j.ajog.2008.01.012] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18355787]
6. Turner, L.C.; Shepherd, J.P.; Wang, L.; Bunker, C.H.; Lowder, J.L. Hysterectomy surgery trends: A more accurate depiction of the last decade?. Am. J. Obstet. Gynecol.; 2013; 208, pp. 277.e1-277.e7. [DOI: https://dx.doi.org/10.1016/j.ajog.2013.01.022]
7. 3 Committee Opinion No 701: Choosing the Route of Hysterectomy for Benign Disease. Obstet. Gynecol.; 2017; 129, pp. e155-e159. [DOI: https://dx.doi.org/10.1097/aog.0000000000002112] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28538495]
8. Kalloo, A.N.; Singh, V.K.; Jagannath, S.B.; Niiyama, H.; Hill, S.L.; Vaughn, C.A.; Magee, C.A.; Kantsevoy, S.V. Flexible transgastric peritoneoscopy: A novel approach to diagnostic and therapeutic interventions in the peritoneal cavity. Gastrointest. Endosc.; 2004; 60, pp. 114-117.
9. Ahn, K.H.; Song, J.Y.; Kim, S.H.; Lee, K.W.; Kim, T. Transvaginal single-port natural orifice transluminal endoscopic surgery for benign uterine adnexal pathologies. J. Minim. Invasive Gynecol.; 2012; 19, pp. 631-635.
10. Kaya, C.; Alay, I.; Ekin, M.; Yaşar, L. Hysterectomy by vaginal-assisted natural orifice transluminal endoscopic surgery: Initial experience with twelve cases. J. Turk. Gynecol. Assoc.; 2018; 19, pp. 34-38. [DOI: https://dx.doi.org/10.4274/jtgga.2017.0075]
11. Li, C.-B.; Hua, K.-Q. Transvaginal natural orifice transluminal endoscopic surgery (vNOTES) in gynecologic surgeries: A systematic review. Asian J. Surg.; 2020; 43, pp. 44-51. [DOI: https://dx.doi.org/10.1016/j.asjsur.2019.07.014] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31444108]
12. Kapurubandara, S.; Lowenstein, L.; Salvay, H.; Herijgers, A.; King, J.; Baekelandt, J. Consensus on safe implementation of vaginal natural orifice transluminal endoscopic surgery (vNOTES). Eur. J. Obstet. Gynecol. Reprod. Biol.; 2021; 263, pp. 216-222. [DOI: https://dx.doi.org/10.1016/j.ejogrb.2021.06.019] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/34237485]
13. Baekelandt, J.; De Mulder, P.A.; Le Roy, I.; Mathieu, C.; Laenen, A.; Enzlin, P.; Weyers, S.; Mol, B.W.; Bosteels, J.J. HALON—Hysterectomy by transabdominal laparoscopy or natural orifice transluminal endoscopic surgery: A randomised controlled trial (study protocol). BMJ Open; 2016; 6, e011546. [DOI: https://dx.doi.org/10.1136/bmjopen-2016-011546] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27519922]
14. Miner, P.B. Economic and personal impact of fecal and urinary incon tinence. Gastroenterology; 2004; 126, (Suppl. S1), pp. S8-S13. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/14978633]
15. Barber, M.D.; Maher, C. Epidemiology and outcome assessment of pelvic organ prolapse. Int. Urogynecol. J.; 2013; 24, pp. 1783-1790. [DOI: https://dx.doi.org/10.1007/s00192-013-2169-9] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24142054]
16. Aigmueller, T.; Dungl, A.; Hinterholzer, S.; Geiss, I.; Riss, P. An estimation of the 426 frequency of surgery for posthysterectomy vault prolapse. Int. Urogynecol. J.; 2010; 21, pp. 299-302. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19936593]
17. Dallenbach, P.; Kaelin-Gambirasio, I.; Dubisson, J.B.; Boulvain, M. Risk factors for pelvic 430 organ prolapse repair after hysterectomy. Obstet. Gynecol.; 2007; 110, pp. 625-632. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17766610]
18. Vermeulen, C.K.M.; Veen, J.; Adang, C.; van Leijsen, S.A.L.; Coolen, A.-L.W.M.; Bongers, M.Y. Pelvic organ prolapse after laparoscopic hysterectomy compared with vaginal hysterectomy: The POP-UP study. Int. Urogynecol. J.; 2021; 32, pp. 841-850. [DOI: https://dx.doi.org/10.1007/s00192-020-04591-z]
19. Wang, C.N.; Chung, D.E. Etiology, Diagnosis, and Management of Pelvic Organ Prolapse: Overview. Female Genitourinary and Pelvic Floor Reconstruction; Martins, F.E.; Holm, H.V.; Sandhu, J.S.; McCammon, K.A. Springer: Cham, Switzerland, 2023; [DOI: https://dx.doi.org/10.1007/978-3-031-19598-3_29]
20. Chow, D.; Rodríguez, L.V. Epidemiology and prevalence of pelvic organ prolapse. Curr. Opin. Urol.; 2013; 23, pp. 293-298. [DOI: https://dx.doi.org/10.1097/mou.0b013e3283619ed0] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23619578]
21. Snooks, S.; Swash, M.; Setchell, M.; Henry, M. Injury to innervation of pelvic floor sphincter musculature in childbirth. Lancet; 1984; 324, pp. 546-550. [DOI: https://dx.doi.org/10.1016/s0140-6736(84)90766-9] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/6147604]
22. Hunskaar, S. A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women. Neurourol. Urodyn.; 2008; 27, pp. 749-757. [DOI: https://dx.doi.org/10.1002/nau.20635] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18951445]
23. Doshani, A.; Teo, R.E.C.; Mayne, C.J.; Tincello, D.G. Uterine prolapse. BMJ; 2007; 335, pp. 819-823. [DOI: https://dx.doi.org/10.1136/bmj.39356.604074.be]
24. Radosa, J.C.; Meyberg-Solomayer, G.; Kastl, C.; Radosa, C.G.; Mavrova, R.; Gräber, S.; Baum, S.; Radosa, M.P. Influences of different hysterectomy techniques on patients’ postoperative sexual function and quality of life. J. Sex. Med.; 2014; 11, pp. 2342-2350. [DOI: https://dx.doi.org/10.1111/jsm.12623] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25042204]
25. Achtari, C.; Dwyer, P.L. Sexual function and pelvic floor disorders. Best Pract. Res. Clin. Obstet. Gynaecol.; 2005; 19, pp. 993-1008. [DOI: https://dx.doi.org/10.1016/j.bpobgyn.2005.08.012]
26. Thakar, R.; Sultan, A.H. Hysterectomy and pelvic organ dysfunction. Best Pract. Res. Clin. Obstet. Gynaecol.; 2005; 19, pp. 403-418. [DOI: https://dx.doi.org/10.1016/j.bpobgyn.2005.01.008]
27. Abdelmonem, A.M. Vaginal length and incidence of dyspareunia after total abdominal versus vaginal hysterectomy. Eur. J. Obstet. Gynecol. Reprod. Biol.; 2010; 151, pp. 190-192. [DOI: https://dx.doi.org/10.1016/j.ejogrb.2010.03.031] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20427116]
28. Nulens, K.; Bosteels, J.; De Rop, C.; Baekelandt, J. vNOTES hyster ectomy for large uteri: A retrospective cohort study of 114 pa tients. J. Minim. Invasive Gynecol.; 2021; 28, pp. 1351-1356. [DOI: https://dx.doi.org/10.1016/j.jmig.2020.10.003]
29. Kaya, C.; Alay, I.; Cengiz, H.; Baghaki, S.; Aslan, O.; Ekin, M.; Yaşar, L. Conventional laparoscopy or vaginally assisted natural orifice transluminal endoscopic surgery for adnexal pathologies: A paired sample cross-sectional study. J. Investig. Surg.; 2020; 34, pp. 1185-1190. [DOI: https://dx.doi.org/10.1080/08941939.2020.1789246]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Department of Obstetrics and Gynecology, Diyarbakir Gazi Yasargil Research and Training Hospital, University of Health Sciences, 21070 Diyarbakır, Turkey; [email protected] (M.A.H.); [email protected] (M.B.); [email protected] (B.C.); [email protected] (İ.B.); [email protected] (M.O.); [email protected] (S.A.); [email protected] (C.B.); [email protected] (K.A.); [email protected] (A.D.E.); [email protected] (S.C.O.)
2 Department of Obstetrics and Gynecology, Fethi Sekin City Hospital, University of Health Sciences, 23119 Elazığ, Turkey
3 Department of Obstetrics and Gynecology, Private Batı Hospital, 21070 Diyarbakır, Turkey; [email protected]
4 Department of Obstetrics and Gynecology, Dicle University, 21070 Diyarbakır, Turkey; [email protected]
5 Department of Obstetrics and Gynecology, Fırat University, 23119 Elazığ, Turkey; [email protected]